Multiple halo naevi associated with tocilizumab.

Abstract

Tocilizumab, a humanized monoclonal antibody directed against the interleukin (IL)-6 receptor, is approved for the treatment of rheumatoid arthritis and juvenile idiopathic arthritis (JIA). We describe a case of multiple halo naevi occurring in a patient with a history of JIA treated with tocilizumab. IL-6 is a key cytokine in the setting of cancer through… (More)
DOI: 10.1111/ced.12385

2 Figures and Tables

Topics

  • Presentations referencing similar topics